DSpace at RU >

Search Results

Results 1-14 of 14.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	Ovarian reserve and oocyte maturity in cancer patients	Bastings, L.; Oei, A.L.M.; Beerendonk, C.C.M.
	2009	Immune responses in ovarian cancer patients treated with intraperitoneal 90-Yttrium labeled HMFG1	Oei, A.L.M.
	2009	Secondary ovarian malignancies: frequency, origin, and characteristics.	Waal, Y.R. de; Thomas, C.M.G.; Oei, A.L.M.; Sweep, F.C.; Massuger, L.F.A.G.
	2009	Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.	Gerritzen, L.H.; Hoogerbrugge-van der Linden, N.; Oei, A.L.M.; Nagengast, F.M.; Ham, M.A.P.C. van; Massuger, L.F.A.G.; Hullu, J.A. de
	2008	Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.	Oei, A.L.M.; Sweep, F.C.; Geurts-Moespot, A.; Tienoven, D. van; Mensdorff-Pouilly, S von; Thomas, C.M.G.; Massuger, L.F.A.G.
	2008	The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).	Oei, A.L.M.; Sweep, F.C.; Thomas, C.M.G.; Boerman, O.C.; Massuger, L.F.A.G.
	2008	Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.	Oei, A.L.M.; Sweep, F.C.; Massuger, L.F.A.G.; Olthaar, A.J.; Thomas, C.M.G.
	2008	Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.	Oei, A.L.M.; Moreno, M.; Verheijen, R.H.; Sweep, F.C.; Thomas, C.M.G.; Massuger, L.F.A.G.; Mensdorff-Pouilly, S von
	2007	Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies.	Oei, A.L.M.; Boerman, O.C.; Geurts-Moespot, A.; Eerd-Vismale, J.E.M. van; Tienoven, D. van; Courtenay-Luck, N.; Thomas, C.M.G.; Massuger, L.F.A.G.; Sweep, C.G.J.
	2007	"Owl's eye" cells in a cervical smear of a transplant recipient: don't forget to inform the referring physician.	Oei, A.L.M.; Salet-van de Pol, M.R.J. van de; Borst, S.M.; Berg, A.P. van den; Grefte, J.M.M.
	2007	Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer.	Oei, A.L.M.; Massuger, L.F.A.G.; Oyen, W.J.G.
	2007	Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.	Oei, A.L.M.; Verheijen, R.H.; Seiden, M.V.; Benigno, B.B.; Lopes, A.; Soper, J.T.; Epenetos, A.A.; Massuger, L.F.A.G.
	2006	Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?	Oei, A.L.M.; Massuger, L.F.A.G.; Bulten, J.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.; Hullu, J.A. de
	2006	Surveillance of women at high risk for hereditary ovarian cancer is inefficient.	Oei, A.L.M.; Massuger, L.F.A.G.; Bulten, J.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.; Hullu, J.A. de

1